Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	ATP-dependent activity	KIF9 DDX17 SPAST ACSBG1 CECR2 HELZ CHD9 DDX53 MSH3 DDX43 MORC2 DNAH1	3.80e-06	614	77	12	GO:0140657
GeneOntologyMolecularFunction	5-methylcytosine dioxygenase activity	TET2 TET3	4.39e-05	3	77	2	GO:0070579
GeneOntologyMolecularFunction	transcription coactivator activity	MED20 ZCCHC12 DDX17 TCF20 SS18L1 THRAP3 ZFPM2	1.68e-04	303	77	7	GO:0003713
GeneOntologyMolecularFunction	helicase activity	DDX17 HELZ CHD9 DDX53 DDX43	3.64e-04	158	77	5	GO:0004386
GeneOntologyMolecularFunction	catalytic activity, acting on a nucleic acid	MED20 DUS2 DDX17 CECR2 HELZ CHD9 DDX53 MSH3 DDX43	8.24e-04	645	77	9	GO:0140640
GeneOntologyMolecularFunction	cysteine-type peptidase activity	USP53 CAPN7 USP20 OTUD7B ALG13	8.80e-04	192	77	5	GO:0008234
GeneOntologyMolecularFunction	cysteine-type deubiquitinase activity	USP53 USP20 OTUD7B ALG13	9.89e-04	114	77	4	GO:0004843
GeneOntologyMolecularFunction	deubiquitinase activity	USP53 USP20 OTUD7B ALG13	1.35e-03	124	77	4	GO:0101005
GeneOntologyMolecularFunction	pyrophosphatase activity	PRUNE2 KIF9 DDX17 SPAST LSG1 CHD9 DDX53 DDX43 MORC2 GPN3	1.39e-03	839	77	10	GO:0016462
GeneOntologyMolecularFunction	hydrolase activity, acting on acid anhydrides	PRUNE2 KIF9 DDX17 SPAST LSG1 CHD9 DDX53 DDX43 MORC2 GPN3	1.41e-03	840	77	10	GO:0016817
GeneOntologyMolecularFunction	hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides	PRUNE2 KIF9 DDX17 SPAST LSG1 CHD9 DDX53 DDX43 MORC2 GPN3	1.41e-03	840	77	10	GO:0016818
GeneOntologyMolecularFunction	transcription coregulator activity	MED20 ZCCHC12 DDX17 TCF20 SS18L1 CAMTA1 THRAP3 ZFPM2	1.43e-03	562	77	8	GO:0003712
GeneOntologyMolecularFunction	protein-macromolecule adaptor activity	MED20 ZCCHC12 DDX17 TCF20 CDC42SE2 SS18L1 IRS1 DTX3L CAMTA1 HNRNPA2B1 THRAP3 ZFPM2	1.54e-03	1160	77	12	GO:0030674
GeneOntologyMolecularFunction	ATP hydrolysis activity	KIF9 DDX17 SPAST CHD9 DDX53 DDX43 MORC2	1.55e-03	441	77	7	GO:0016887
GeneOntologyMolecularFunction	molecular adaptor activity	MED20 ZCCHC12 DDX17 TCF20 CDC42SE2 SS18L1 IRS1 DTX3L CAMTA1 HNRNPA2B1 THRAP3 ZFPM2 AXIN2	1.92e-03	1356	77	13	GO:0060090
GeneOntologyMolecularFunction	ubiquitin-like protein peptidase activity	USP53 USP20 OTUD7B ALG13	1.95e-03	137	77	4	GO:0019783
GeneOntologyMolecularFunction	ribonucleoside triphosphate phosphatase activity	KIF9 DDX17 SPAST LSG1 CHD9 DDX53 DDX43 MORC2 GPN3	2.91e-03	775	77	9	GO:0017111
GeneOntologyMolecularFunction	RNA helicase activity	DDX17 DDX53 DDX43	3.41e-03	78	77	3	GO:0003724
GeneOntologyMolecularFunction	HMG box domain binding	POU3F2 POU3F3	3.52e-03	23	77	2	GO:0071837
GeneOntologyMolecularFunction	ATP-dependent activity, acting on RNA	DDX17 DDX53 DDX43	3.66e-03	80	77	3	GO:0008186
Domain	-	CUX2 POU1F1 POU3F2 POU3F3	4.14e-06	27	76	4	1.10.260.40
Domain	Lambda_DNA-bd_dom	CUX2 POU1F1 POU3F2 POU3F3	5.57e-06	29	76	4	IPR010982
Domain	POU	POU1F1 POU3F2 POU3F3	3.49e-05	16	76	3	SM00352
Domain	POU_2	POU1F1 POU3F2 POU3F3	3.49e-05	16	76	3	PS00465
Domain	POU_dom	POU1F1 POU3F2 POU3F3	3.49e-05	16	76	3	IPR000327
Domain	POU_3	POU1F1 POU3F2 POU3F3	3.49e-05	16	76	3	PS51179
Domain	Pou	POU1F1 POU3F2 POU3F3	3.49e-05	16	76	3	PF00157
Domain	POU_1	POU1F1 POU3F2 POU3F3	3.49e-05	16	76	3	PS00035
Domain	POU	POU1F1 POU3F2 POU3F3	4.23e-05	17	76	3	IPR013847
Domain	TF_POU_3	POU3F2 POU3F3	9.75e-05	4	76	2	IPR016362
Domain	P-loop_NTPase	KIF9 DDX17 SPAST LSG1 HELZ CHD9 DDX53 MSH3 DDX43 CAMTA1 GPN3 DNAH1	1.51e-04	848	76	12	IPR027417
Domain	DEAD_ATP_HELICASE	DDX17 DDX53 DDX43	2.68e-04	31	76	3	PS00039
Domain	RNA-helicase_DEAD-box_CS	DDX17 DDX53 DDX43	3.24e-04	33	76	3	IPR000629
Domain	Q_MOTIF	DDX17 DDX53 DDX43	4.55e-04	37	76	3	PS51195
Domain	RNA_helicase_DEAD_Q_motif	DDX17 DDX53 DDX43	4.55e-04	37	76	3	IPR014014
Domain	MIT	SPAST CAPN7	7.20e-04	10	76	2	SM00745
Domain	MIT	SPAST CAPN7	7.20e-04	10	76	2	PF04212
Domain	-	DDX17 SPAST LSG1 HELZ CHD9 DDX53 MSH3 DDX43 GPN3 DNAH1	8.57e-04	746	76	10	3.40.50.300
Domain	Helicase_C	DDX17 CHD9 DDX53 DDX43	9.52e-04	107	76	4	PF00271
Domain	HELICc	DDX17 CHD9 DDX53 DDX43	9.52e-04	107	76	4	SM00490
Domain	Homeobox_CS	CUX2 POU1F1 POU3F2 POU3F3 TLX1	9.68e-04	186	76	5	IPR017970
Domain	Helicase_C	DDX17 CHD9 DDX53 DDX43	9.85e-04	108	76	4	IPR001650
Domain	HELICASE_CTER	DDX17 CHD9 DDX53 DDX43	1.02e-03	109	76	4	PS51194
Domain	HELICASE_ATP_BIND_1	DDX17 CHD9 DDX53 DDX43	1.02e-03	109	76	4	PS51192
Domain	DEXDc	DDX17 CHD9 DDX53 DDX43	1.02e-03	109	76	4	SM00487
Domain	Helicase_ATP-bd	DDX17 CHD9 DDX53 DDX43	1.05e-03	110	76	4	IPR014001
Domain	OTU	OTUD7B ALG13	1.24e-03	13	76	2	PF02338
Domain	MIT	SPAST CAPN7	1.44e-03	14	76	2	IPR007330
Domain	OTU	OTUD7B ALG13	1.66e-03	15	76	2	PS50802
Domain	OTU_dom	OTUD7B ALG13	1.66e-03	15	76	2	IPR003323
Domain	UBA-like	VPS13D UBAP2 OTUD7B	2.26e-03	64	76	3	IPR009060
Domain	Homeobox	CUX2 POU1F1 POU3F2 POU3F3 TLX1	2.65e-03	234	76	5	PF00046
Domain	HOMEOBOX_1	CUX2 POU1F1 POU3F2 POU3F3 TLX1	2.75e-03	236	76	5	PS00027
Domain	HOX	CUX2 POU1F1 POU3F2 POU3F3 TLX1	2.80e-03	237	76	5	SM00389
Domain	HOMEOBOX_2	CUX2 POU1F1 POU3F2 POU3F3 TLX1	2.91e-03	239	76	5	PS50071
Domain	Homeobox_dom	CUX2 POU1F1 POU3F2 POU3F3 TLX1	2.91e-03	239	76	5	IPR001356
Domain	DEAD/DEAH_box_helicase_dom	DDX17 DDX53 DDX43	3.28e-03	73	76	3	IPR011545
Domain	DEAD	DDX17 DDX53 DDX43	3.28e-03	73	76	3	PF00270
Domain	-	CUX2 POU1F1 POU3F2 POU3F3 TLX1	5.93e-03	283	76	5	1.10.10.60
Domain	UBA	VPS13D UBAP2	6.60e-03	30	76	2	SM00165
Pubmed	Expression of a large family of POU-domain regulatory genes in mammalian brain development.	POU1F1 POU3F2 POU3F3	2.08e-07	6	77	3	2739723
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	USP53 TET2 VPS13D PTPN13 UBAP2 SPAST TCF20 LSG1 HELZ IRS1 MTCL1 CIC	4.13e-07	861	77	12	36931259
Pubmed	RNF43 inhibits WNT5A-driven signaling and suppresses melanoma invasion and resistance to the targeted therapy.	PTPN13 TCF20 ROR1 ZDHHC5 TENM1 HELZ HNRNPA2B1	2.00e-06	263	77	7	34702444
Pubmed	A mutation in the tuft mouse disrupts TET1 activity and alters the expression of genes that are crucial for neural tube closure.	TET2 CECR2 TET3	2.94e-06	13	77	3	26989192
Pubmed	Arginine methylation and ubiquitylation crosstalk controls DNA end-resection and homologous recombination repair.	SART1 TET2 UBAP2 DDX17 DSG1 UBR4 HNRNPA2B1 THRAP3 ALG13	3.65e-06	551	77	9	34728620
Pubmed	Tet1 controls meiosis by regulating meiotic gene expression.	TET2 SS18L1 TET3	3.73e-06	14	77	3	23151479
Pubmed	Satb2 is a postmitotic determinant for upper-layer neuron specification in the neocortex.	CUX2 POU3F2 POU3F3	4.66e-06	15	77	3	18255031
Pubmed	Acute loss of TET function results in aggressive myeloid cancer in mice.	TET2 TET3	4.84e-06	2	77	2	26607761
Pubmed	The putative tumor suppressor gene PTPN13/PTPL1 induces apoptosis through insulin receptor substrate-1 dephosphorylation.	PTPN13 IRS1	4.84e-06	2	77	2	17638892
Pubmed	Epigenetic silencing of TET2 and TET3 induces an EMT-like process in melanoma.	TET2 TET3	4.84e-06	2	77	2	27852070
Pubmed	TET proteins regulate Drosha expression and impact microRNAs in iNKT cells.	TET2 TET3	4.84e-06	2	77	2	39364402
Pubmed	Protein-tyrosine phosphatase PTPL1/FAP-1 triggers apoptosis in human breast cancer cells.	PTPN13 IRS1	4.84e-06	2	77	2	12354757
Pubmed	Ten-eleven translocation (Tet) methylcytosine dioxygenase-dependent viral DNA demethylation mediates in vivo hepatitis B virus (HBV) biosynthesis.	TET2 TET3	4.84e-06	2	77	2	38179947
Pubmed	TET2 and TET3 loss disrupts small intestine differentiation and homeostasis.	TET2 TET3	4.84e-06	2	77	2	37414790
Pubmed	TET enzymes control antibody production and shape the mutational landscape in germinal centre B cells.	TET2 TET3	4.84e-06	2	77	2	31120187
Pubmed	Role of Chromatin Remodeling Genes and TETs in the Development of Human Midbrain Dopaminergic Neurons.	TET2 TET3	4.84e-06	2	77	2	32367481
Pubmed	Molecular pathogenesis of progression to myeloid leukemia from TET-insufficient status.	TET2 TET3	4.84e-06	2	77	2	32126143
Pubmed	Distinct roles for TET family proteins in regulating human erythropoiesis.	TET2 TET3	4.84e-06	2	77	2	28167661
Pubmed	Retinol and ascorbate drive erasure of epigenetic memory and enhance reprogramming to naïve pluripotency by complementary mechanisms.	TET2 TET3	4.84e-06	2	77	2	27729528
Pubmed	Proteome-scale mapping of binding sites in the unstructured regions of the human proteome.	USP53 PRUNE2 CUX2 UBAP2 UBR4 CAMTA1 CIC OTUD7B	5.11e-06	430	77	8	35044719
Pubmed	PRISMA and BioID disclose a motifs-based interactome of the intrinsically disordered transcription factor C/EBPα.	SART1 MED20 TET2 DDX17 SPAST TCF20 CHD9 RRM1 MORC2 HNRNPA2B1 THRAP3 CIC	5.37e-06	1103	77	12	34189442
Pubmed	Neuron-specific protein network mapping of autism risk genes identifies shared biological mechanisms and disease-relevant pathologies.	ASRGL1 UBAP2 DDX17 SPAST DSG1 ACSBG1 UBR4 TENM1 KCNQ2 HELZ PCCA THRAP3	7.42e-06	1139	77	12	36417873
Pubmed	Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB.	SART1 PTPN13 DDX17 LSG1 ZDHHC5 MUC16 PCCA HNRNPA2B1 THRAP3 OTUD7B	8.32e-06	777	77	10	35844135
Pubmed	Expression of TET and 5-HmC in Trophoblast Villi of Women with Normal Pregnancy and with Early Pregnancy Loss.	TET2 TET3	1.45e-05	3	77	2	30074219
Pubmed	Induced DNA demethylation by targeting Ten-Eleven Translocation 2 to the human ICAM-1 promoter.	TET2 TET3	1.45e-05	3	77	2	24194590
Pubmed	TET proteins in malignant hematopoiesis.	TET2 TET3	1.45e-05	3	77	2	19923888
Pubmed	Selective targeting of TET catalytic domain promotes somatic cell reprogramming.	TET2 TET3	1.45e-05	3	77	2	32024762
Pubmed	Tet Enzymes Regulate Telomere Maintenance and Chromosomal Stability of Mouse ESCs.	TET2 TET3	1.45e-05	3	77	2	27184841
Pubmed	Tet proteins can convert 5-methylcytosine to 5-formylcytosine and 5-carboxylcytosine.	TET2 TET3	1.45e-05	3	77	2	21778364
Pubmed	Tet family proteins and 5-hydroxymethylcytosine in development and disease.	TET2 TET3	1.45e-05	3	77	2	22569552
Pubmed	Postnatal DNA demethylation and its role in tissue maturation.	TET2 TET3	1.45e-05	3	77	2	29795194
Pubmed	Class III POU genes: generation of homopolymeric amino acid repeats under GC pressure in mammals.	POU3F2 POU3F3	1.45e-05	3	77	2	8703082
Pubmed	Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1.	TET2 TET3	1.45e-05	3	77	2	19372391
Pubmed	Hyperglycemia affects global 5-methylcytosine and 5-hydroxymethylcytosine in blood genomic DNA through upregulation of SIRT6 and TETs.	TET2 TET3	1.45e-05	3	77	2	30987683
Pubmed	Improvement of Foxp3 stability through CNS2 demethylation by TET enzyme induction and activation.	TET2 TET3	1.45e-05	3	77	2	29048538
Pubmed	Mechanisms of TET protein-mediated DNA demethylation and its role in the regulation of mouse development.	TET2 TET3	1.45e-05	3	77	2	25608811
Pubmed	Genetic characterization of TET1, TET2, and TET3 alterations in myeloid malignancies.	TET2 TET3	1.45e-05	3	77	2	19420352
Pubmed	Overexpression of TET dioxygenases in seminomas associates with low levels of DNA methylation and hydroxymethylation.	TET2 TET3	1.45e-05	3	77	2	28218476
Pubmed	Ascorbate induces ten-eleven translocation (Tet) methylcytosine dioxygenase-mediated generation of 5-hydroxymethylcytosine.	TET2 TET3	1.45e-05	3	77	2	23548903
Pubmed	5-Hydroxymethylcytosine-mediated active demethylation is required for mammalian neuronal differentiation and function.	TET2 TET3	1.45e-05	3	77	2	34919053
Pubmed	Distinct and overlapping control of 5-methylcytosine and 5-hydroxymethylcytosine by the TET proteins in human cancer cells.	TET2 TET3	1.45e-05	3	77	2	24958354
Pubmed	One-step generation of mice carrying mutations in multiple genes by CRISPR/Cas-mediated genome engineering.	TET2 TET3	1.45e-05	3	77	2	23643243
Pubmed	Tissue-specific DNA demethylation is required for proper B-cell differentiation and function.	TET2 TET3	1.45e-05	3	77	2	27091986
Pubmed	Stage-specific regulation of DNA methylation by TET enzymes during human cardiac differentiation.	TET2 TET3	1.45e-05	3	77	2	34879277
Pubmed	Oxygen regulation of TET enzymes.	TET2 TET3	1.45e-05	3	77	2	33410283
Pubmed	Effect of aging on 5-hydroxymethylcytosine in brain mitochondria.	TET2 TET3	1.45e-05	3	77	2	22445327
Pubmed	Control of Foxp3 stability through modulation of TET activity.	TET2 TET3	1.45e-05	3	77	2	26903244
Pubmed	Loss of Tet enzymes compromises proper differentiation of embryonic stem cells.	TET2 TET3	1.45e-05	3	77	2	24735881
Pubmed	Differential expression of ten-eleven translocation genes in endometrial cancers.	TET2 TET3	1.45e-05	3	77	2	28349832
Pubmed	The Sox2 regulatory region 2 functions as a neural stem cell-specific enhancer in the telencephalon.	POU3F2 POU3F3	1.45e-05	3	77	2	16547000
Pubmed	Role of Tet proteins in 5mC to 5hmC conversion, ES-cell self-renewal and inner cell mass specification.	TET2 TET3	1.45e-05	3	77	2	20639862
Pubmed	Ten-Eleven Translocation Genes are Downregulated in Endometriosis.	TET2 TET3	1.45e-05	3	77	2	26917261
Pubmed	Iron-dependent epigenetic modulation promotes pathogenic T cell differentiation in lupus.	TET2 TET3	1.45e-05	3	77	2	35499082
Pubmed	TET proteins regulate the lineage specification and TCR-mediated expansion of iNKT cells.	TET2 TET3	1.45e-05	3	77	2	27869820
Pubmed	TET2 promotes histone O-GlcNAcylation during gene transcription.	TET2 TET3	1.45e-05	3	77	2	23222540
Pubmed	Alternation of ten-eleven translocation 1, 2, and 3 expression in eutopic endometrium of women with endometriosis-associated infertility.	TET2 TET3	1.45e-05	3	77	2	30130982
Pubmed	Regulation of DNA methylation signatures on NF-κB and STAT3 pathway genes and TET activity in cigarette smoke extract-challenged cells/COPD exacerbation model in vitro.	TET2 TET3	1.45e-05	3	77	2	32342329
Pubmed	High-throughput analyses of hnRNP H1 dissects its multi-functional aspect.	SART1 KIF9 UBAP2 DDX17 TCF20 SUGCT SS18L1 CAMTA1 PCCA HNRNPA2B1 OTUD7B	1.51e-05	1021	77	11	26760575
Pubmed	Conserved transcriptional regulation by BRN1 and BRN2 in neocortical progenitors drives mammalian neural specification and neocortical expansion.	CUX2 POU3F2 POU3F3	2.32e-05	25	77	3	39271675
Pubmed	Tet-mediated DNA demethylation regulates specification of hematopoietic stem and progenitor cells during mammalian embryogenesis.	TET2 TET3	2.89e-05	4	77	2	35235365
Pubmed	Loss of TET proteins in regulatory T cells promotes abnormal proliferation, Foxp3 destabilization and IL-17 expression.	TET2 TET3	2.89e-05	4	77	2	30726915
Pubmed	Mutually repressive interaction between Brn1/2 and Rorb contributes to the establishment of neocortical layer 2/3 and layer 4.	POU3F2 POU3F3	2.89e-05	4	77	2	26951672
Pubmed	Reprogramming of the paternal genome upon fertilization involves genome-wide oxidation of 5-methylcytosine.	TET2 TET3	2.89e-05	4	77	2	21321204
Pubmed	Paradoxical association of TET loss of function with genome-wide DNA hypomethylation.	TET2 TET3	2.89e-05	4	77	2	31371502
Pubmed	Differential regulation of the ten-eleven translocation (TET) family of dioxygenases by O-linked β-N-acetylglucosamine transferase (OGT).	TET2 TET3	2.89e-05	4	77	2	24394411
Pubmed	Activation-induced cytidine deaminase alters the subcellular localization of Tet family proteins.	TET2 TET3	2.89e-05	4	77	2	23028748
Pubmed	Deterministic Somatic Cell Reprogramming Involves Continuous Transcriptional Changes Governed by Myc and Epigenetic-Driven Modules.	TET2 TET3	2.89e-05	4	77	2	30554962
Pubmed	TET2 and TET3 regulate GlcNAcylation and H3K4 methylation through OGT and SET1/COMPASS.	TET2 TET3	2.89e-05	4	77	2	23353889
Pubmed	Structure and evolution of four POU domain genes expressed in mouse brain.	POU3F2 POU3F3	2.89e-05	4	77	2	1565620
Pubmed	Genome-wide DNA methylation analysis reveals a potential mechanism for the pathogenesis and development of uterine leiomyomas.	COL6A3 IRS1	2.89e-05	4	77	2	23818951
Pubmed	TET1 Directs Chondrogenic Differentiation by Regulating SOX9 Dependent Activation of Col2a1 and Acan In Vitro.	TET2 TET3	2.89e-05	4	77	2	33134768
Pubmed	Phosphorylation of TET proteins is regulated via O-GlcNAcylation by the O-linked N-acetylglucosamine transferase (OGT).	TET2 TET3	2.89e-05	4	77	2	25568311
Pubmed	Tet inactivation disrupts YY1 binding and long-range chromatin interactions during embryonic heart development.	TET2 TET3	2.89e-05	4	77	2	31541101
Pubmed	Structure and regulation of the human growth hormone-releasing hormone receptor gene.	POU1F1 POU3F2	2.89e-05	4	77	2	9482665
Pubmed	Tet2 and Tet3 cooperate with B-lineage transcription factors to regulate DNA modification and chromatin accessibility.	TET2 TET3	2.89e-05	4	77	2	27869616
Pubmed	Selective influence of Sox2 on POU transcription factor binding in embryonic and neural stem cells.	POU3F2 POU3F3	2.89e-05	4	77	2	26265007
Pubmed	The intrinsic and extrinsic effects of TET proteins during gastrulation.	TET2 TET3	2.89e-05	4	77	2	35908548
Pubmed	Type 2 diabetes risk alleles near ADCY5, CDKAL1 and HHEX-IDE are associated with reduced birthweight.	TCF20 IRS1 ADCY5	2.94e-05	27	77	3	20490451
Pubmed	A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation.	SART1 PTPN13 UBAP2 DSG1 LSG1 HELZ C16orf96 MORC2 THRAP3	3.19e-05	724	77	9	36232890
Pubmed	Systematic proteomics of endogenous human cohesin reveals an interaction with diverse splicing factors and RNA-binding proteins required for mitotic progression.	SART1 TET2 DDX17 UBR4 HNRNPA2B1 THRAP3	3.22e-05	272	77	6	31010829
Pubmed	DNA demethylation fine-tunes IL-2 production during thymic regulatory T cell differentiation.	TET2 TET3	4.82e-05	5	77	2	36880575
Pubmed	The class III POU factor Brn-4 interacts with other class III POU factors and the heterogeneous nuclear ribonucleoprotein U.	POU3F2 POU3F3	4.82e-05	5	77	2	9105675
Pubmed	Dynamic expression of TET1, TET2, and TET3 dioxygenases in mouse and human placentas throughout gestation.	TET2 TET3	4.82e-05	5	77	2	29108636
Pubmed	Cooperative function of POU proteins and SOX proteins in glial cells.	POU3F2 POU3F3	4.82e-05	5	77	2	9632656
Pubmed	The subventricular zone is the developmental milestone of a 6-layered neocortex: comparisons in metatherian and eutherian mammals.	CUX2 POU3F2	4.82e-05	5	77	2	19726493
Pubmed	CD4 expression in effector T cells depends on DNA demethylation over a developmentally established stimulus-responsive element.	TET2 TET3	4.82e-05	5	77	2	35304452
Pubmed	Loss of TET2 and TET3 in regulatory T cells unleashes effector function.	TET2 TET3	4.82e-05	5	77	2	31043609
Pubmed	TET is targeted for proteasomal degradation by the PHD-pVHL pathway to reduce DNA hydroxymethylation.	TET2 TET3	4.82e-05	5	77	2	32963106
Pubmed	Lineage-specific functions of TET1 in the postimplantation mouse embryo.	TET2 TET3	4.82e-05	5	77	2	28504700
Pubmed	Loss of adipose TET proteins enhances β-adrenergic responses and protects against obesity by epigenetic regulation of β3-AR expression.	TET2 TET3	4.82e-05	5	77	2	35737830
Pubmed	CRL4(VprBP) E3 ligase promotes monoubiquitylation and chromatin binding of TET dioxygenases.	TET2 TET3	4.82e-05	5	77	2	25557551
Pubmed	Frequent somatic mutations in epigenetic regulators in newly diagnosed chronic myeloid leukemia.	TET2 TET3	4.82e-05	5	77	2	28452984
Pubmed	TET-Mediated Sequestration of miR-26 Drives EZH2 Expression and Gastric Carcinogenesis.	TET2 TET3	4.82e-05	5	77	2	28923852
Pubmed	Ten-eleven translocation (Tet) and thymine DNA glycosylase (TDG), components of the demethylation pathway, are direct targets of miRNA-29a.	TET2 TET3	4.82e-05	5	77	2	23820384
Pubmed	TIF1γ inhibits lung adenocarcinoma EMT and metastasis by interacting with the TAF15/TBP complex.	COL6A3 DDX17 SUGCT RRM1 THRAP3	5.00e-05	179	77	5	36261009
Pubmed	Tet2- and Tet3- Mediated Cytosine Hydroxymethylation in Six2 Progenitor Cells in Mice Is Critical for Nephron Progenitor Differentiation and Nephron Endowment.	TET2 TET3 AXIN2	5.43e-05	33	77	3	36522157
Pubmed	Ubiquitin-specific peptidase 2a (USP2a) deubiquitinates and stabilizes β-catenin.	USP53 USP20 OTUD7B	5.43e-05	33	77	3	30323974
Pubmed	MYC multimers shield stalled replication forks from RNA polymerase.	SART1 DUS2 DDX17 TCF20 DSG1 SGCD LSG1 PCCA HNRNPA2B1 THRAP3	6.46e-05	989	77	10	36424410
Pubmed	Essential roles of the histone methyltransferase ESET in the epigenetic control of neural progenitor cells during development.	CUX2 POU3F2 POU3F3	6.49e-05	35	77	3	22991445
Pubmed	The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery.	SART1 UBAP2 TCF20 DSG1 LSG1 ZDHHC5 POU3F3 IRS1 DTX3L HNRNPA2B1 THRAP3	6.69e-05	1203	77	11	29180619
Interaction	TLE3 interactions	TBX15 TET2 DDX17 TCF20 CAPN7 CECR2 HELZ CIC TLX1 ALG13	1.45e-06	376	76	10	int:TLE3
Interaction	ERG interactions	TET2 TCF20 SS18L1 UBR4 MSH3 HNRNPA2B1 CIC	2.11e-05	223	76	7	int:ERG
Interaction	RNF43 interactions	PTPN13 DDX17 TCF20 ROR1 ZDHHC5 TENM1 HELZ HNRNPA2B1 ALG13	3.21e-05	427	76	9	int:RNF43
Interaction	FMR1 interactions	UBAP2 SPAST TCF20 CECR2 UBR4 MTCL1 HNRNPA2B1 THRAP3 ZFPM2 ALG13	3.22e-05	536	76	10	int:FMR1
Cytoband	3q21.1	DTX3L ADCY5	5.17e-04	20	77	2	3q21.1
Cytoband	20q13.3	SS18L1 KCNQ2	5.17e-04	20	77	2	20q13.3
Cytoband	2p13.1	ACTG2 TET3	1.50e-03	34	77	2	2p13.1
GeneFamily	POU class homeoboxes and pseudogenes	POU1F1 POU3F2 POU3F3	3.00e-05	23	48	3	523
GeneFamily	DEAD-box helicases	DDX17 DDX53 DDX43	1.87e-04	42	48	3	499
GeneFamily	OTU domain containing	OTUD7B ALG13	9.15e-04	17	48	2	669
CoexpressionAtlas	dev gonad_e11.5_M_GonadVasMes_Flk_top-relative-expression-ranked_500	MED20 COL6A3 CACNA2D1 PTPN13 FAT3 ROR1 MUC16 IRS1 ZFPM2	1.45e-05	418	74	9	gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_500
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_500	CACNA2D1 CUX2 FAT3 ROR1 ACTG2 DTX3L MTCL1 ADCY5	8.49e-05	407	74	8	gudmap_developingLowerUrinaryTract_e14.5_ urethra_500
CoexpressionAtlas	dev gonad_e11.5_M_GonadVasMes_Flk_k-means-cluster#4_top-relative-expression-ranked_500	COL6A3 CACNA2D1 FAT3 ROR1 MUC16 IRS1	8.52e-05	207	74	6	gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_k4_500
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_top-relative-expression-ranked_500	CACNA2D1 FAT3 ROR1 ACTG2 MSH3 DTX3L MTCL1 ADCY5	8.64e-05	408	74	8	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_500
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_top-relative-expression-ranked_500	CACNA2D1 CUX2 FAT3 ROR1 TENM1 KCNQ2 MSH3 DTX3L	1.18e-04	427	74	8	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_500
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PRUNE2 COL6A3 SGCD FAT3 ROR1 ACTG2 IRS1 MTCL1 ZFPM2	4.05e-11	188	77	9	3177b2c1723268d330d3e9f24f9e24492ace6286
ToppCell	Control-Fibroblasts-Airway_smooth_muscle\|Control / group, cell type (main and fine annotations)	PRUNE2 CACNA2D1 SUGCT SGCD FAT3 ACTG2 ADCY5 ZFPM2	9.33e-10	180	77	8	d0de12749ef0f51f0931c6e7b9b99966bdbc3ec1
ToppCell	COVID-19-Fibroblasts-Airway_smooth_muscle\|COVID-19 / group, cell type (main and fine annotations)	USP53 PRUNE2 COL6A3 CACNA2D1 SUGCT ROR1 ACTG2 ADCY5	1.26e-09	187	77	8	464a0c3b92b778911b5f9cd73642e09e3472063a
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PRUNE2 COL6A3 CACNA2D1 SGCD ACTG2 IRS1 ADCY5 ZFPM2	1.37e-09	189	77	8	7ab1cfc1657277858339f7258a0c4ae9cb42fdf8
ToppCell	LPS_only-Stromal_mesenchymal-Lung_smooth_muscle\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PRUNE2 COL6A3 SGCD ACTG2 IRS1 COX4I2 ADCY5 ZFPM2	1.49e-09	191	77	8	08042952431ca1a6fd7dfc13f36eb28643979598
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PRUNE2 COL6A3 CACNA2D1 SGCD ACTG2 IRS1 COX4I2 ADCY5	1.49e-09	191	77	8	7853ac7dff649150e6ff27cd4c8cf7c1fc034ed4
ToppCell	nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-ASMC\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	PRUNE2 CACNA2D1 SGCD FAT3 ACTG2 ADCY5 ZFPM2	2.11e-08	173	77	7	cb6389536195443633adb06e5f1b7483530773d1
ToppCell	PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	USP53 COL6A3 CACNA2D1 PTPN13 SUGCT SGCD ROR1	3.60e-08	187	77	7	a9316e2818217ec5feae9cf8816f7249803caee6
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PRUNE2 COL6A3 SGCD ACTG2 IRS1 MTCL1 ZFPM2	3.74e-08	188	77	7	293f2fa99f5f96aa7fd2b2a5cc94ff60eeaabe11
ToppCell	Control-Stromal_mesenchymal-Lung_smooth_muscle\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PRUNE2 SGCD FAT3 ROR1 ACTG2 ADCY5 ZFPM2	3.87e-08	189	77	7	45e588b2a4ad9e3ff74e22d9d627ed3571f3b8b8
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PRUNE2 SGCD ACTG2 IRS1 COX4I2 ADCY5 ZFPM2	4.32e-08	192	77	7	992d08092edbc68c47b945deb8708379738c239a
ToppCell	nucseq-Mesenchymal-Myocytic\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	COL6A3 SUGCT ACTG2 IRS1 COX4I2 ADCY5 ZFPM2	4.63e-08	194	77	7	2d66091097e106c7bee22e5281f50724700bdf8d
ToppCell	COVID-19-Fibroblasts\|COVID-19 / group, cell type (main and fine annotations)	USP53 COL6A3 CACNA2D1 SUGCT SGCD ROR1 ZFPM2	5.15e-08	197	77	7	fb847f2277609c31fffcdf49517243ce0684facf
ToppCell	background-Hepatic_Stellate_cells\|background / Sample and Cell Type and Tumor Cluster (all cells)	COL6A3 CACNA2D1 PTPN13 SGCD FAT3 ADCY5 ZFPM2	5.33e-08	198	77	7	bd11b0e9e80449aab979a02c1023e0638c431c7c
ToppCell	3'-Distal_airway-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	USP53 COL6A3 CACNA2D1 SGCD FAT3 CATSPERB	6.62e-07	178	77	6	09475e522dc1b8cf9ff1c25de5d1e3082b162948
ToppCell	3'-Distal_airway-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	USP53 COL6A3 CACNA2D1 SGCD FAT3 CATSPERB	6.62e-07	178	77	6	35de8f791b0e78a6caf52ff095f05e204a59e828
ToppCell	3'-Distal_airway-Mesenchymal-Fibroblastic-fibroblastic_type_2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	USP53 COL6A3 CACNA2D1 SGCD FAT3 CATSPERB	6.62e-07	178	77	6	000d25f3f13cc76cf39c46c312c6fafc2ea4f368
ToppCell	Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	PRUNE2 ACTG2 IRS1 MTCL1 ADCY5 ZFPM2	7.30e-07	181	77	6	25915e2500430a902db37d79a749ce2990b69810
ToppCell	5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PRUNE2 COL6A3 CACNA2D1 SGCD ACTG2 ADCY5	7.30e-07	181	77	6	b116c68393d8836bac080f81a8fcbeb52e0403e7
ToppCell	LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PRUNE2 COL6A3 SGCD ACTG2 IRS1 ZFPM2	8.29e-07	185	77	6	e64e8c98dd88d91f6501d3fb10b60fd2f3c90af3
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PRUNE2 SGCD ACTG2 IRS1 MTCL1 ZFPM2	8.56e-07	186	77	6	6add08d4ca019ff2864acdd5ec2c66a59a574591
ToppCell	Control-Fibroblasts-Other_FB\|Control / group, cell type (main and fine annotations)	COL6A3 CACNA2D1 SUGCT SGCD FAT3 ZFPM2	8.83e-07	187	77	6	bd3739c4a52aa1ba5deffd778e113a9800f7e158
ToppCell	PCW_05-06-Mesenchymal-Mesenchymal_myocytic\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	PRUNE2 TENM1 ACTG2 IRS1 MTCL1 COX4I2	9.39e-07	189	77	6	b6d5dec55bf352f6ae19d8f488ae70aa10fb9a8f
ToppCell	Mesenchymal-airway_smooth_muscle_cell\|World / Lineage, Cell type, age group and donor	PRUNE2 ACTG2 IRS1 MTCL1 ADCY5 ZFPM2	9.69e-07	190	77	6	645e56b02edc3702c7db917b8ecd5eed0decaf71
ToppCell	Control-Fibroblasts\|Control / group, cell type (main and fine annotations)	USP53 COL6A3 CACNA2D1 SGCD FAT3 ZFPM2	9.69e-07	190	77	6	3a42a9b98d954685d38a741f44545898d0e3e9ce
ToppCell	Control-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PRUNE2 SGCD ROR1 ACTG2 ADCY5 ZFPM2	9.99e-07	191	77	6	b133ee1c0e58d00ddd2e4e05b01fd04947524c18
ToppCell	COVID-19-Fibroblasts-Other_FB\|COVID-19 / group, cell type (main and fine annotations)	COL6A3 CACNA2D1 SUGCT SGCD ROR1 ZFPM2	1.06e-06	193	77	6	e6b75be08e33c1de079fb5c02f0b4468128b369c
ToppCell	nucseq-Mesenchymal-Myocytic-Myocytic_2\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	COL6A3 SUGCT SGCD ACTG2 IRS1 ZFPM2	1.06e-06	193	77	6	5de87fc94a6e58899ef4124cf4887ed3ff96163a
ToppCell	Children_(3_yrs)-Mesenchymal\|Children_(3_yrs) / Lineage, Cell type, age group and donor	USP53 COL6A3 CACNA2D1 SGCD FAT3 ZFPM2	1.16e-06	196	77	6	bc94909f9b2dc08a59eef1914148b69720569c8f
ToppCell	PCW_13-14-Mesenchymal\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	COL6A3 CACNA2D1 SGCD FAT3 ROR1 ZFPM2	1.20e-06	197	77	6	73a2085d2682d636726a5432d572ae2a3fbe1c3f
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	COL6A3 CACNA2D1 SGCD FAT3 ROR1 ZFPM2	1.23e-06	198	77	6	17dc055e2a289496d9c5cdbf3297bdf906dc6d22
ToppCell	PCW_10-12-Mesenchymal\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	COL6A3 CACNA2D1 SGCD FAT3 ROR1 ZFPM2	1.27e-06	199	77	6	a09292de4c4447b8eee55d401808e43b817321cc
ToppCell	Control_saline-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast\|Control_saline / Treatment groups by lineage, cell group, cell type	PRUNE2 SGCD ACTG2 IRS1 ADCY5 ZFPM2	1.31e-06	200	77	6	c5e051f1aac8dda376c342a9932785a23450e073
ToppCell	Control_saline-Mesenchymal_myocytic-Myofibroblastic\|Control_saline / Treatment groups by lineage, cell group, cell type	PRUNE2 COL6A3 SGCD ACTG2 IRS1 ZFPM2	1.31e-06	200	77	6	9d5b3c2dcfa55d50acc2ce2c319d51aa525d4cd1
ToppCell	LPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	PRUNE2 COL6A3 SGCD ACTG2 IRS1 ZFPM2	1.31e-06	200	77	6	87827041663013f5e7273168dc8709d69840e7ce
ToppCell	LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	PRUNE2 COL6A3 ACTG2 IRS1 MTCL1 ZFPM2	1.31e-06	200	77	6	c596a53c0b63c9deaac7d99fcbdd94ecfa96b86c
ToppCell	LPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	PRUNE2 COL6A3 SGCD ACTG2 IRS1 ZFPM2	1.31e-06	200	77	6	8988f113708eef7d9d2a6a6c1bcfd7c8f9804d3e
ToppCell	LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	PRUNE2 COL6A3 ACTG2 IRS1 ADCY5 ZFPM2	1.31e-06	200	77	6	08bf8c00eee6468215edb3611296bfc8784c4d56
ToppCell	LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	PRUNE2 ACTG2 IRS1 MTCL1 ADCY5 ZFPM2	1.31e-06	200	77	6	dcdaec3ca3a3024dc1b8788c417003f84c2bffdc
ToppCell	Children_(3_yrs)-Mesenchymal-airway_smooth_muscle_cell-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	PRUNE2 FAT3 ACTG2 ADCY5 ZFPM2	7.36e-06	155	77	5	cd7d95cbcad248670e531d80bb83c55e36ebc573
ToppCell	wk_15-18-Mesenchymal-Myofibro_&_SMC-Myofibro_2\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	COL6A3 FAT3 ACTG2 IRS1 MTCL1	7.83e-06	157	77	5	b9d04ee417c0d8ea0801d10f1c54e138587009fd
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-high_Fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	COL6A3 ROR1 IRS1 ZFPM2 AXIN2	8.33e-06	159	77	5	330ecbba97d47bc818a5e8d1d84b05d056bd831e
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-high_Fibroblast-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	COL6A3 ROR1 IRS1 ZFPM2 AXIN2	8.33e-06	159	77	5	cbb331eb689d8cea9e1146ba85e0a05d23301c47
ToppCell	Children_(3_yrs)-Mesenchymal-airway_smooth_muscle_cell-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	PRUNE2 ACTG2 IRS1 ADCY5 ZFPM2	9.68e-06	164	77	5	e3983f655cdba308fb192182829f17bef99ce0ba
ToppCell	facs-Heart-LV-18m-Mesenchymal-valve_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ROR1 MTCL1 COX4I2 ADCY5 ZFPM2	1.25e-05	173	77	5	d78397e65e997ddb995111a810f0e2a4f67d0765
ToppCell	facs-Heart-LV-18m-Mesenchymal-valve_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ROR1 MTCL1 COX4I2 ADCY5 ZFPM2	1.25e-05	173	77	5	3c852ffe22f4a5b632463086b08c669310684e80
ToppCell	E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_prolif\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PRUNE2 COL6A3 ACSBG1 MUC16 ADCY5	1.29e-05	174	77	5	4da79da7a09ee1e345102c5331675ebcdbe56171
ToppCell	Children_(3_yrs)-Mesenchymal-airway_smooth_muscle_cell\|Children_(3_yrs) / Lineage, Cell type, age group and donor	PRUNE2 ACTG2 IRS1 ADCY5 ZFPM2	1.40e-05	177	77	5	b59967219f7d874805768e247c0eb2bc4d4420c8
ToppCell	3'-GW_trimst-2-LargeIntestine-Mesenchymal-myocytic-SMC_(PLPP2+)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PRUNE2 FAT3 ACTG2 MTCL1 ADCY5	1.48e-05	179	77	5	e860dca9b28ac5af61804bfd729cd39257cdb352
ToppCell	facs-Lung-Endomucin-24m-Mesenchymal-pericyte_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SGCD ACTG2 MTCL1 COX4I2 TMEM200A	1.60e-05	182	77	5	be9c312a44868d4ee266a64d066feb8c5bce5687
ToppCell	facs-Lung-Endomucin-24m-Mesenchymal-Pericyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SGCD ACTG2 MTCL1 COX4I2 TMEM200A	1.60e-05	182	77	5	74dbb706bcaa0f8c922bf3b0424bce5bb27167fa
ToppCell	10x5'v1-week_17-19-Lymphocytic_T-T_NK-Treg\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	USP53 TENM1 ACTG2 MORC2 TMEM200A	1.64e-05	183	77	5	5fb933acfe6bc555c90dba71e75d4be658763945
ToppCell	wk_20-22-Mesenchymal-Myofibro_&_SMC-Myofibro_3\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	COL6A3 FAT3 ROR1 IRS1 AXIN2	1.64e-05	183	77	5	f4ea7113ce9099222743d9ff02388d3d8a9e987b
ToppCell	21-Trachea-Mesenchymal-Airway_Smooth_Muscle\|Trachea / Age, Tissue, Lineage and Cell class	COL6A3 SGCD ACTG2 IRS1 ZFPM2	1.69e-05	184	77	5	86a96cd88e50eacad1f0badfbbf6dc626f41725e
ToppCell	human_hepatoblastoma-Hepatic_Stellate_cells\|World / Sample and Cell Type and Tumor Cluster (all cells)	COL6A3 CACNA2D1 PTPN13 FAT3 ZFPM2	1.78e-05	186	77	5	cb1fc4b9140666b43415e21c9b434dc9b144e9d0
ToppCell	Control-Fibroblasts-Alveolar_FB\|Control / group, cell type (main and fine annotations)	USP53 COL6A3 SGCD FAT3 ZFPM2	1.82e-05	187	77	5	92d468dde81125d51daf7abd4703741abe1ab91c
ToppCell	Pericytes-SSc-ILD_02\|World / lung cells shred on cell class, cell subclass, sample id	TBX15 COL6A3 CACNA2D1 ACTG2 COX4I2	1.87e-05	188	77	5	f16ff998393bf1954bbf10caab15173bdb104ac1
ToppCell	wk_15-18-Mesenchymal-Myofibro_&_SMC-Myofibro_1\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	COL6A3 FAT3 ROR1 ACTG2 IRS1	1.97e-05	190	77	5	d24af6af3271e34afab744352afd28be8a7cc5c3
ToppCell	PCW_05-06-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	FAT3 ACTG2 IRS1 MTCL1 RRM1	1.97e-05	190	77	5	e83fa8b711aa79a1767818474f1c193b674b1c31
ToppCell	Control-Stromal_mesenchymal\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SGCD FAT3 ACTG2 ADCY5 ZFPM2	2.02e-05	191	77	5	14057205ddb9b4bbc582d1358d13cf36d979a61b
ToppCell	human_hepatoblastoma-Hepatic_Stellate_cells\|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells)	COL6A3 CACNA2D1 PTPN13 FAT3 ZFPM2	2.02e-05	191	77	5	78c3c2fdb68c3407f2436f90e1e6a780bbf8b79e
ToppCell	nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	USP53 COL6A3 SGCD FAT3 ZFPM2	2.02e-05	191	77	5	6688cee34beee4f151ac17fccbc9c26a9aad72e1
ToppCell	nucseq-Mesenchymal-Myocytic-Myocytic_2-SCMF\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	COL6A3 SUGCT SGCD IRS1 ZFPM2	2.07e-05	192	77	5	67e845e513e76e820f55e2f0d15eb16f2944d05c
ToppCell	nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	USP53 COL6A3 SGCD FAT3 ZFPM2	2.07e-05	192	77	5	99ce9e3c4c50cf64ebb62145f2b5420efa0db309
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell\|Children_(3_yrs) / Lineage, Cell type, age group and donor	USP53 COL6A3 CACNA2D1 SGCD FAT3	2.12e-05	193	77	5	99525545552b371c86b18b6ea6f4897dc6e9a9ec
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	USP53 COL6A3 CACNA2D1 SGCD FAT3	2.17e-05	194	77	5	e93de9428c986b8943fc169258847c650cfab0e5
ToppCell	Control-Fibroblasts-Intermediate_pathological_FB\|Control / group, cell type (main and fine annotations)	COL6A3 CACNA2D1 SUGCT SGCD ZFPM2	2.17e-05	194	77	5	03a269f75a481ea54aea8e6444605db8d6df493d
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	COL6A3 CACNA2D1 FAT3 ROR1 PCCA	2.17e-05	194	77	5	b1bb0f846d2865efdd9bc8842b16b9d069785882
ToppCell	Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	COL6A3 CACNA2D1 SGCD FAT3 ZFPM2	2.17e-05	194	77	5	35f132cc38ac133be01834ed0946188aa0757eb4
ToppCell	LA-02._Fibroblast_II\|LA / Chamber and Cluster_Paper	USP53 COL6A3 CHD9 CATSPERB ZFPM2	2.17e-05	194	77	5	234d1494c114cce77c619708bbcd8d5ce805f19b
ToppCell	COVID-19-lung-Pericytes/_Smooth_Muscle\|lung / Disease (COVID-19 only), tissue and cell type	PRUNE2 CACNA2D1 ACTG2 COX4I2 ADCY5	2.17e-05	194	77	5	5e1e0513a54ec4cf0b247ec85c9fbc68dfac1da3
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	COL6A3 CACNA2D1 FAT3 ROR1 PCCA	2.23e-05	195	77	5	0e55fa5b3cbeb7baee3d4ac272a3bf80381ec937
ToppCell	RA-02._Fibroblast_II\|RA / Chamber and Cluster_Paper	USP53 COL6A3 CHD9 CATSPERB ZFPM2	2.23e-05	195	77	5	6a02ebbeb3199447ddce64d92d8809436e040eba
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	COL6A3 SGCD FAT3 ACTG2 ZFPM2	2.28e-05	196	77	5	1522958a92e0126326a9f0d9fb1c5b5c50b001ea
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	COL6A3 CACNA2D1 SGCD FAT3 ROR1	2.28e-05	196	77	5	1450cb69c5bf469e97c03bf1890f6f7c54165b8a
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	COL6A3 SGCD FAT3 ACTG2 ZFPM2	2.28e-05	196	77	5	1c8294014713684b50885e638668f2ce75f357f0
ToppCell	Bronchial-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	PRUNE2 SGCD FAT3 ACTG2 ADCY5	2.28e-05	196	77	5	9830fb3da7a60f65ad463e9054bb77c06b025e4d
ToppCell	nucseq-Mesenchymal-Fibroblastic\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	USP53 COL6A3 SGCD FAT3 ZFPM2	2.28e-05	196	77	5	7d8505dac15fa59935ccf592afc54b04c4c6554f
ToppCell	Bronchial-NucSeq-Stromal-Myofibroblastic-Muscle_perivascular_immune_recruiting\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	TBX15 PRUNE2 COL6A3 ACTG2 ADCY5	2.34e-05	197	77	5	cfb3dc4b401800e33c82cfc3baee69dbbd16ac8c
ToppCell	Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_myofibroblast\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	PRUNE2 COL6A3 SUGCT SGCD ZFPM2	2.34e-05	197	77	5	0dd71e399f253787fa546a7e90c5373180b89ffd
ToppCell	Bronchial-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	PRUNE2 SGCD FAT3 ACTG2 ADCY5	2.34e-05	197	77	5	bf0520a94ebb1d2f94de9f526d17e0b0e8fe7052
ToppCell	COVID-19-Fibroblasts-Intermediate_pathological_FB\|COVID-19 / group, cell type (main and fine annotations)	COL6A3 CACNA2D1 SUGCT SGCD ROR1	2.34e-05	197	77	5	f1c8936986123a3151140c374fcd62d6705c530b
ToppCell	Tracheal-10x3prime_v2-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	PRUNE2 SGCD FAT3 ROR1 ACTG2	2.40e-05	198	77	5	cbb63b255bdc92a557c5db1f08f7766ed9346607
ToppCell	Parenchymal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	PRUNE2 FAT3 TENM1 ACTG2 ADCY5	2.40e-05	198	77	5	d1827e3707b929e3a3562989a0c11537d344e164
ToppCell	nucseq-Mesenchymal\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	USP53 COL6A3 SGCD FAT3 ZFPM2	2.40e-05	198	77	5	8f52243ca8b9ba68a75ae411506a3a6de258eb97
ToppCell	Fetal_29-31_weeks-Mesenchymal\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	COL6A3 CACNA2D1 SGCD FAT3 ZFPM2	2.40e-05	198	77	5	21cf4d81386761d09d0f6829c01c198e5524176d
ToppCell	Mesenchymal\|World / Lineage, Cell type, age group and donor	COL6A3 CACNA2D1 SGCD FAT3 ZFPM2	2.46e-05	199	77	5	4bac110c2b3609f6ee5d0e3275da0824a6240270
ToppCell	LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	PRUNE2 COL6A3 ACTG2 IRS1 ZFPM2	2.46e-05	199	77	5	e9820d5fb4e8b46973c4c50ac5db8fb4a1bf603b
ToppCell	Tracheal-10x3prime_v2-Stromal-Myofibroblastic\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	PRUNE2 SUGCT ACTG2 COX4I2 ADCY5	2.46e-05	199	77	5	534dcfe8b65ad92bb8d749d1c7036ad4807e09cd
ToppCell	Tracheal-NucSeq-Stromal-Peri/Epineurial_-NAF_epineurial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	TBX15 OR2B11 PTPN13 ROR1 ZFPM2	2.46e-05	199	77	5	9c2db0bb94cba71a3cc1827844da090e213e0258
ToppCell	LPS_IL1RA_TNF-Mesenchymal_myocytic\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	PRUNE2 ACTG2 IRS1 ADCY5 ZFPM2	2.52e-05	200	77	5	f599e4b051ac3dad11ad437e98dc8ea6754cca53
ToppCell	Bronchial-NucSeq-Stromal-Myofibroblastic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	PRUNE2 SGCD FAT3 ACTG2 ADCY5	2.52e-05	200	77	5	a66449b22b39dd6987fc2c3ed160d24564234ced
ToppCell	mild\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	TET2 DDX17 HELZ DTX3L HNRNPA2B1	2.52e-05	200	77	5	12f1685ce8f218433068e090c9d839cd5a1910bf
ToppCell	Bronchus_Control_(B.)-Stromal-TX-Fibroblasts-4\|Bronchus_Control_(B.) / Sample group, Lineage and Cell type	TBX15 COL6A3 SGCD ROR1 ZFPM2	2.52e-05	200	77	5	54b18c92daaa3b3368c0c46134b0c27e10c8dbb0
ToppCell	LPS_only-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast\|LPS_only / Treatment groups by lineage, cell group, cell type	PRUNE2 ACTG2 IRS1 MTCL1 ZFPM2	2.52e-05	200	77	5	593bf6a7c557437db9a9249a5058a46014179ef6
ToppCell	LPS_anti-TNF-Mesenchymal_myocytic\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	PRUNE2 COL6A3 ACTG2 IRS1 ADCY5	2.52e-05	200	77	5	67dcbd86fbc79fd585d0793f979e4aac100326c9
ToppCell	LPS_only-Mesenchymal_myocytic-Myofibroblastic\|LPS_only / Treatment groups by lineage, cell group, cell type	PRUNE2 COL6A3 ACTG2 IRS1 ZFPM2	2.52e-05	200	77	5	02cae2c296a13ad4cbb53bca7a86d64629d67d66
ToppCell	Parenchymal-NucSeq-Stromal-Fibroblastic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	USP53 COL6A3 SGCD FAT3 ZFPM2	2.52e-05	200	77	5	311fab076f2ceb258e3970eb21e39344b894042a
ToppCell	Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	COL6A3 SUGCT SGCD TENM1 IRS1	2.52e-05	200	77	5	58b38f9a484ee94191091a0659ed62ebed2d4a14
ToppCell	Hippocampus-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3\|Hippocampus / BrainAtlas - Mouse McCarroll V32	TBX15 SLC43A1 C16orf96 COX4I2	6.77e-05	126	77	4	b0bc61be1d4ce8114077c524fedfdf89128bcf12
Disease	Autistic behavior	CUX2 POU3F3 TET3	9.48e-07	8	77	3	C0856975
Disease	obsessive-compulsive disorder, Tourette syndrome	HACE1 POU1F1 CAMTA1	4.25e-05	26	77	3	EFO_0004242, EFO_0004895
Disease	Neurodevelopmental Disorders	SPAST KCNQ2 ADCY5 ALG13	1.05e-04	93	77	4	C1535926
Disease	colon adenoma (is_marker_for)	TET2 AXIN2	1.40e-04	7	77	2	DOID:0050912 (is_marker_for)
Disease	BMI-adjusted waist circumference, forced expiratory volume	CUX2 OTUD7B	2.39e-04	9	77	2	EFO_0004314, EFO_0007789
Disease	long QT syndrome (implicated_via_orthology)	KCNH6 KCNQ2	2.98e-04	10	77	2	DOID:2843 (implicated_via_orthology)
Disease	HOMA-B	CUX2 ADCY5 ZFPM2	4.07e-04	55	77	3	EFO_0004469
Disease	vascular endothelial growth factor measurement	ROR1 MTCL1 ZFPM2	4.29e-04	56	77	3	EFO_0004762
Disease	gestational age	SUGCT CAMTA1 TET3 ADCY5	4.76e-04	138	77	4	EFO_0005112
Disease	oral squamous cell carcinoma (is_marker_for)	TET2 PTPN13 AXIN2	6.06e-04	63	77	3	DOID:0050866 (is_marker_for)
Disease	platelet component distribution width	PRUNE2 KIF9 CATSPERB IRS1 CAMTA1 ADCY5 ZFPM2 TLX1	7.87e-04	755	77	8	EFO_0007984
Disease	response to acetylsalicylate	CACNA2D1 KIF9	7.88e-04	16	77	2	GO_1903492
Disease	MAJOR AFFECTIVE DISORDER 2	CUX2 KCNQ2	8.91e-04	17	77	2	C1839839
Disease	response to radiation, Urinary retention	COL6A3 CAMTA1	8.91e-04	17	77	2	GO_0009314, HP_0000016
Disease	muscular dystrophy (is_implicated_in)	COL6A3 SGCD	8.91e-04	17	77	2	DOID:9884 (is_implicated_in)
Disease	Intellectual Disability	CUX2 TCF20 POU3F3 TET3 CIC ALG13	1.12e-03	447	77	6	C3714756
Disease	alcohol drinking	CUX2 FAT3 ROR1	1.26e-03	81	77	3	EFO_0004329
Disease	hair color	TYR TET2 TCF20 SGCD AXIN2	1.34e-03	311	77	5	EFO_0003924
Disease	lymphocyte count	TET2 OR2B11 UBAP2 SPAST CDC42SE2 ACSBG1 SGCD HELZ RRM1 ADCY5 ZFPM2	1.42e-03	1464	77	11	EFO_0004587
Disease	Dystonia	COL6A3 KCNQ2 ADCY5	1.50e-03	86	77	3	C0013421
Disease	smoking status measurement, chronic obstructive pulmonary disease	TET2 MTCL1 ADCY5	1.60e-03	88	77	3	EFO_0000341, EFO_0006527
Disease	peripheral neuropathy, response to antimicrotubule agent	SUGCT ZFPM2	1.64e-03	23	77	2	EFO_0003100, EFO_0005260
Disease	response to antiviral drug, cirrhosis of liver	KCNQ2 MTCL1	1.79e-03	24	77	2	EFO_0001422, EFO_0010123
Disease	fasting blood glucose measurement, HOMA-B, fasting blood insulin measurement	SGCD ADCY5	1.94e-03	25	77	2	EFO_0004465, EFO_0004466, EFO_0004469
Disease	Iniencephaly	CECR2 RRM1	2.43e-03	28	77	2	C0152234
Disease	Tethered Cord Syndrome	CECR2 RRM1	2.43e-03	28	77	2	C0080218
Disease	Spinal Cord Myelodysplasia	CECR2 RRM1	2.43e-03	28	77	2	C0344479
Disease	Exencephaly	CECR2 RRM1	2.43e-03	28	77	2	C0266453
Disease	Neurenteric Cyst	CECR2 RRM1	2.43e-03	28	77	2	C0027806
Disease	glucose metabolism disease (implicated_via_orthology)	KCNH6 IRS1	2.43e-03	28	77	2	DOID:4194 (implicated_via_orthology)
Disease	Acrania	CECR2 RRM1	2.43e-03	28	77	2	C0702169
Disease	Diastematomyelia	CECR2 RRM1	2.43e-03	28	77	2	C0011999
Disease	Seizures	CUX2 HACE1 KCNQ2 TET3	2.57e-03	218	77	4	C0036572
Disease	Craniorachischisis	CECR2 RRM1	2.61e-03	29	77	2	C0152426
Disease	mammographic density percentage	TBX15 TET3	2.61e-03	29	77	2	EFO_0006502

Protein segments in the cluster

Peptide	Gene	Start	Entry
GSGVPYGPINNMKNV	SUGCT	351	Q9HAC7
QTYGGGGLKAEMVSS	CAMTA1	496	Q9Y6Y1
KESQYGFTPGNGQMP	ALG13	711	Q9NP73
GLAPSLGIMNSTYNG	CATSPERB	81	Q9H7T0
AYATSTGGIVNKMVG	ASRGL1	181	Q7L266
NTAYMSNGGLGSLKV	AXIN2	206	Q9Y2T1
ANNVLSGGTTMYPGI	ACTG2	296	P63267
MSGSKSVSPPGYAAQ	ADCY5	1	O95622
SSLSGKMYSGSQAPG	CUX2	1021	O14529
KMYSGSQAPGGIQEI	CUX2	1026	O14529
LGQISGPSQDGSMYA	CECR2	731	Q9BXF3
NNRTSPGMAQKGYSE	MTCL1	1726	Q9Y4B5
VGNGGSKYSQEVMQS	OTUD7B	581	Q6GQQ9
GPMFKNTSVGLLYSG	MUC16	12581	Q8WXI7
LQYSPDMGKGSATFN	MUC16	14086	Q8WXI7
GPNMGGKSSYIKQVA	MSH3	896	P20585
AVMGYKPGSGVVTAS	LSG1	611	Q9H089
MGYGKSGQNAQGILT	ASAH2	121	Q9NR71
KGVNGSSQAPTSGKY	ZFPM2	1106	Q8WW38
SKGYSLLGPGSQNSM	KCNH6	756	Q9H252
YAANGMGPLKVLSGS	SLC43A1	541	O75387
QSKGGYGGGMPANVQ	CDC42SE2	61	Q9NRR3
MVQKSRNGGVYPGPS	KCNQ2	1	O43526
SSPSNGIDMGYNGNK	HACE1	336	Q8IYU2
GIDMGYNGNKTPRSQ	HACE1	341	Q8IYU2
NGTIMCYGQTGAGKT	KIF9	86	Q9HAQ2
AGGNMSIQFLGTVYK	PCCA	621	P05165
ELSNYICMGGKGPST	IRS1	461	P35568
MLTGVSGGAKYAQNG	HELZ	491	P42694
RPGSKTYVVTGNMGS	DSG1	386	Q02413
QIGQYGNGLKSGSMR	MORC2	96	Q9Y6X9
LVNMGSSQKTISYGG	OR2B11	86	Q5JQS5
SLKGQPSISGGMYEA	DNAH1	1881	Q9P2D7
AMKPPGAQGSQSTYT	CDK2AP2	61	O75956
MNNGTPESAYILQGG	CHD9	2236	Q3L8U1
QLVMGPAGSGKSTYC	GPN3	6	Q9UHW5
KVMGGYDFPGSNSNI	CAPN7	381	Q9Y6W3
SYLANMGGPSSLGTT	C16orf96	716	A6NNT2
TSYGIQKGNQPEGSM	DTX3L	601	Q8TDB6
NKSGPGAYESGIMVS	CACNA2D1	781	P54289
ISNMSYIGGTNQTGK	COL6A3	106	P12111
RGMKLYGNNGVSSTA	FAT3	236	Q8TDW7
YTSGTTGNPKGVMLS	ACSBG1	281	Q96GR2
AQTGTGKTLSYLMPG	DDX53	266	Q86TM3
MVGIAQTGSGKTLAY	DDX17	211	Q92841
DVNMGCPKQYSTKGG	DUS2	111	Q9NX74
CPKQYSTKGGMGAAL	DUS2	116	Q9NX74
QSKTKGYAGTPGFMA	GRK1	346	Q15835
LYSQPGGFTVNGMLS	POU3F3	221	P20264
AQTGTGKTLCYLMPG	DDX43	286	Q9NXZ2
GTTRGGGKMSPYTNC	COX4I2	26	Q96KJ9
NNAAGYSCGPGTLKM	PTPN13	2076	Q12923
YSCGPGTLKMNGKLS	PTPN13	2081	Q12923
STLGSQGQTGKLMYV	MED20	51	Q9H944
APLSQGSSGIMELYG	PRUNE2	376	Q8WUY3
SSQYKSSMALGPGAG	TMEM200A	356	Q86VY9
GNQPSTYGVMAGSLT	POU1F1	61	P28069
LPGNSKMEAYGGQLG	TBX15	456	Q96SF7
MTYPGNTGLLATKSN	TENM1	1631	Q9UKZ4
APSYSGLSMVSGVKQ	SPAST	266	Q9UBP0
GGLLYSQPSFTVNGM	POU3F2	186	P20265
LTQMVSGPASYSGPK	CIC	376	Q96RK0
GVPMQGQGTIGNYVS	SS18L1	161	O75177
GGNLGKVYQPGSMLS	USP53	11	Q70EK8
GMGITVFGNKSQKPY	ROR1	896	Q01973
GLPDMTGSVYNKTQT	UBAP2	1011	Q5T6F2
SQMGSTLPSGAGYQS	THRAP3	281	Q9Y2W1
SNYGPMKSGNFGGSR	HNRNPA2B1	311	P22626
YIAGTNGNSNGLVPM	RRM1	261	P23921
STMPGSVGPQVYKVG	SGCD	11	Q92629
IPIGTYGQMKNGSTP	TYR	151	P14679
VMSPSGGYTQLLQGA	TMEM86B	66	Q8N661
YMAGNKDPVTTGTPQ	TCF20	91	Q9UGU0
GQYSGGPSMSPKRTN	TET3	1436	O43151
TPYIVLSGSGKSMNA	SART1	781	O43290
PRGLTGMKNLGNSCY	USP20	141	Q9Y2K6
LGRSMSYSSQKAQPG	ZDHHC5	631	Q9C0B5
PLTGSYNVNMALAGG	TLX1	96	P31314
LNSTGMYVANTKPGG	UBR4	2321	Q5T4S7
TSKQYTGNSNMPGGL	TET2	601	Q6N021
TSGGSGYKNNGPGEM	ZCCHC12	321	Q6PEW1
YAGQKTSPGMTNVFS	VPS13D	2346	Q5THJ4